Ericsun Life Science Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 06-07-2024
- Paid Up Capital ₹ 3.00 M
as on 06-07-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 11.25%
(FY 2022)
- Profit -112.66%
(FY 2022)
- Ebitda 99.07%
(FY 2022)
- Net Worth -2.89%
(FY 2022)
- Total Assets 9.00%
(FY 2022)
About Ericsun Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Aaryaman Sharma and Braj Sharma serve as directors at the Company.
- CIN/LLPIN
U24232RJ2010PTC033467
- Company No.
033467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Alwar, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ericsun Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Braj Sharma  | Director | 06-Dec-2010 | Current |
| Aaryaman Sharma | Director | Current |
Financial Performance and Corporate Structure Insights of Ericsun Life Science.
Ericsun Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.25% increase. The company also saw a substantial fall in profitability, with a 112.66% decrease in profit. The company's net worth dipped by a decrease of 2.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ericsun Life Science?
In 2018, Ericsun Life Science had a promoter holding of 63.67% and a public holding of 36.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
5 years 7 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ericsun Life Science?
Unlock and access historical data on people associated with Ericsun Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of May 30, 2013, Ericsun Life Science has raised a total of ₹ 2.9 M, with the most recent deal valued at ₹ 2.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
